The effect of oral propranolol on left ventricular ejection fraction, left ventricular volumes, cardiac output, and segmental wall motion was assessed with multigated blood pool imaging both at rest and during supine exercise in 15 patients with angina pectoris. Propranolol had no effect on resting left ventricular ejection fractions. Before propranolol, they did not change during exercise, whereas after propranolol the ejection fractions increased slightly. Exercise 
SUMMARY
The effect of oral propranolol on left ventricular ejection fraction, left ventricular volumes, cardiac output, and segmental wall motion was assessed with multigated blood pool imaging both at rest and during supine exercise in 15 patients with angina pectoris. Propranolol had no effect on resting left ventricular ejection fractions. Before propranolol, they did not change during exercise, whereas after propranolol the ejection fractions increased slightly. Exercise left ventricular ejection fractions increased with propranolol in three patients with resting left ventricular ejection fractions of <40 per cent.
More specifically, left ventricular end-diastolic volume index, end-systolic volume index, stroke volume index, and cardiac index were not altered significantly at rest or during exercise by propranolol. Exercise left ventricular ejection fractions were increased in five and unchanged in eight patients by propranolol. Those patients with increases in left ventricular ejection fractions had a greater change in left ventricular end-diastolic volume indices and a greater change in left ventricular end-systolic volume indices during exercise while on propranolol. Left ventricular segmental wall motion was not altered significantly during exercise by propranolol.
We conclude that: (1) Left ventricular functional resp3nses to propranolol during exercise are heterogeneous and not easily predicted; (2) propranolol causes no consistent deterioration in exercise left ventricular ejection fraction even in-patients with resting left ventricular ejection fractions <40 per cent; (3) increased exercise left ventricular ejection fraction with propranolol is contributed to by significant increases in end-diastolic volume during exercise; and (4) gated blood pool imaging is a useful method for characterising rest and exercise left ventricular ejection fractions and left ventricular volumes during propranolol therapy.
The beneficial effects of propranolol on exerciseinduced myocardial ischaemia are well known. 1 The administration of propranolol inhibits the positive inotropic and chronotropic responses to local and circulating catecholamines, often resulting in less frequent angina pectoris and improved exercise tolerance. In some patients, however, left ventricular function may deteriorate with propranolol treatment resulting in congestive heart failure. Previous studies using the acute administration of intravenous propranolol in man *This work was supported by an NIH Ischaemic SCOR grant and the Harry S Moss Heart Fund.
Received for publication 6 November 1980 have failed to document a consistent negative effect on left ventricular function in the basal state. [2] [3] [4] [5] In addition, the effects of oral propranolol on myocardial function at rest have not been characterised completely. [6] [7] [8] Since the effects of propranolol should be most pronounced during periods of sympathetic stimulation (such as exercise), and since the chronic oral effects of propranolol may be different from those produced by single dose intravenous treatment it seems important to gested that oral propranolol improves left ventricular ejection fraction during exercise in patients with coronary artery disease.8-'0 The present study was performed to assess the effects of oral propranolol on resting and exercising left ventricular performance in individuals with angina pectoris, using the technique of multigated equilibrium blood pool imaging. We specifically wished to determine whether: (1) chronic oral propranolol treatment increases left ventricular ejection fraction during exercise; (2) propranolol administration has any consistent beneficial or detrimental effect on left ventricular volumes that might not be apparent if only left ventricular ejection fraction is analysed; and (3) whether there are identifiable patient subgroups that have different left ventricular functional responses to propranolol during exercise.
Patients and methods

PATIENT POPULATION
The study population consisted of 15 patients with angina pectoris (13 male and 2 female) with a mean age of 56 4 years (range, 39 to 73 years) ( Table 1) . In all patients propranolol treatment was instituted for the treatment of angina pectoris. M  400  150  300  2  66  F  160  300  300  3  40  M  160  450  600  4  61  M  80  450  300   5  65   M  80  450  450  6  39  M  60  150  150  7  53  M  320  300  600  8  57   M  120  150  150  9  62  M  80  150  300  10  61  M  320  150  150  11  64  M  80  150  150  12  68  M  160  150  150  13  40  M  160  600  600  14  53  M  80  150  150  15  44  F  160  300  300 The diagnosis of coronary artery disease was based on a history of angina pectoris and: (1) (Table 1 ). Four of the 15 patients experienced no improvement in exercise tolerance or chest pain while on propranolol, and one patient had slight deterioration in exercise capacity (less work performed) without clinical evidence of congestive heart failure. In addition, one patient developed intolerance to propranolol, manifest by excessive fatigue, which resolved after discontinuation of the drug. In the seven patients with previous infarction there was good agreement between the location of resting wall motion abnormalities and the site of previous infarction. Left ventricular functional indices before and after propranolol were compared at the highest equivalent work level achieved during both examinations.
HEART RATE AND DOUBLE PRODUCT Both resting and peak exercise heart rates were lower while on propranolol (Tables 2 and 3) . Mean resting heart rates before and after propranolol were 79 + 10 beats/min and 65 + 10 beats/min, respectively. Mean peak exercise heart rate was 113 ± 15 beats/min before treatment and 97 + 12 beats/min after propranolol. Both differences were statistically significant (p < 0 01). The mean resting double product was lower after propranolol (105±24x102 vs 81±15x102) (p<0 01), as was the mean peak exercise double product (185 ± 62 x 102 vs 148 ± 30 x 102) (p < 0 02). Four patients showed no blunting of exercise heart rate response during propranolol; nevertheless, three of these (mi/m2) (ml/", 2) (mi/n 2) (I/min per nzi) 
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Abbreviations are the same as in Table 2 .
four did show an improvement in left ventricular ejection fraction.
LV END-DIASTOLIC AND END-SYSTOLIC VOLUMES
Mean resting end-diastolic volume index did not change with propranolol (80+29-2 ml/m2 before propranolol, 85+29 3 ml/m2 after propranolol) ( Fig. 1 ) (Tables 2 and 3) . Similarly, peak exercise left ventricular end-diastolic volume index did not change significantly (92 + 291 ml/m2 before propranolol, 101 + 38-4 ml/m2 after propranolol). Left ventricular end-diastolic volume index, however, did increase significantly (p <0 01) with exercise both before and after propranolol treatment. Before treatment, the mean rise with exercise was 17+ 13 per cent, and after propranolol the mean rise with exercise was 20 + 20 per cent. There was no correlation (r <0 5) between the magnitude of reduction in resting heart rate and the degree of increase in resting left ventricular end-diastolic volume index with propranolol.
Mean resting left ventricular end-systolic volume index did not change before (38 + 26-2 ml/M2) or after (39 + 291 ml/m2) propranolol (Fig. 2) ( Tables 2 and 3) . Similarly, mean peak exercise left ventricular end-systolic volume indices did not change during propranolol (39 + 28 4 ml/m2 before and 42+35 1 mIum2 during propranolol). In addition, there was no significant change in left ventricular end-systolic volume index with exercise either before or after propranolol.
STROKE VOLUME AND CARDIAC OUTPUT
The mean resting stroke volume index before propranolol was 42 + 10-6 mI m2, whereas after propranolol it was 46±10 5 mu/m2 (NS) (Fig. 3) ( Tables 2 and 3 ). Mean peak exercise stroke volume indices were similar before and during propranolol (52 + 17-6 ml/m2 before and 59 + 14 6 ml/m2 during propranolol) (NS). There was a significant increase in stroke volume index with exercise in both groups. Before propranolol, stroke volume index rose by 10 + 10-3 ml/m2 with exercise, Exercise LV function durinig propranolol whereas during propranolol treatment, stroke volume index rose by 14 ± 11 1 ml/m2 with exercise.
The mean resting cardiac index was not different before or after propranolol (3 3 ± 0-76 1/min per m2 and 3 00± 0 75 1/min per m2, respectively), nor was the cardiac index at peak exercise (5 -8 ± 2-04 1/min per m2 before and 5-7 + 1-68 1/min per m2 after the drug) (Fig. 4) ( Tables 2 and 3 ). Cardiac index, however, rose significantly (p<0 001) with exercise, and this rise was not altered by propranolol (2-6± 1 58 1/min per m2 before and 27+ 1-31 1/min per m2 after propranolol). 4 Effect of propranolol on rest and exercise cardiac index. The format is as in previous figures. Though cardiac index increased with exercise in both groups, no effect of propranolol was seen.
LEFT VENTRICULAR EJECTION FRACTION
The mean resting left ventricular ejection fraction before propranolol was 0-60 + 016, and after propranolol it was 0 61±0 18 (NS) (Fig. 5) . The mean peak exercise left ventricular ejection fraction was not different before or after propranolol treatment, 063±0-18 vs 0 65±0-18, respectively. Before propranolol treatment, there was no significant rise in mean left ventricular ejection fraction with exercise. After propranolol, however, mean left ventricular ejection fraction rose from 0 -61 ± 0 18 to 0-65±0 18 with exercise, a difference which, though small, was statistically significant (p < 0 05).
Data regarding interobserver, intraobserver, and individual patient variability suggest, however, that an absolute change in left ventricular ejection fraction of 0 05 or greater should be present to consider a change in left ventricular ejection fraction significant.17 Applying this criterion to the individual patient data, the response of the left ventricular ejection fraction to exercise before and after propranolol treatment can be recategorised (Fig. 6 ). Before propranolol, left ventricular ejection fraction increased with exercise in five of the 15 patients (33%), was unchanged in five of the 15 (Fig. 6) . Fig. 6 group with improved left ventricular ejection fractions compared with the patients with unchanged ejection fractions (33 + 11 1 ml/m2 vs 6+7 1 mI/m2, respectively; p<0O001). It is unlikely that this was the result solely of alterations in heart rate, since the mean peak heart rates were equivalent in both groups (91 + 13 6 improved group vs 97 + 9 0 unchanged group) [NS] ). In addition, the magnitude of change in heart rate from rest to exercise, was similar. Similarly after propranolol, the mean change in left ventricular end-systolic volume indices with exercise *was larger (10 + 10-4 ml/m2 vs-1 + 5*8 ml/m2, p < 0 025) in the group with an improved exercise left ventricular ejection fraction response compared with those with unchanged left ventricular ejection fraction responses during exercise. Four patients increased their exercise capacity after propranolol resulting in a further increase in double product. Two of these four reached the equivalent double product of the pretreatment exercise test, whereas in the remaining two, the double product remained diminished (Tables 2  and 3 ). Only one of these four (case 3) had a substantial increase in left ventricular ejection fraction with the increased workload.
WALL MOTION ANALYSIS
In the 15 patients, there was a total of 75 left ventricular wall segments available for evaluation (five segments/patient). The imaging projection used does not allow visualisation of all wall segments, hence abnormalities in the anterior and inferoposterior regions will not be visualised directly. None the less, the development of abnormalities in these areas during exercise has the potential for effecting global left ventricular function and thus could be detected indirectly by alterations in left ventricular ejection fraction. In the seven patients with previous myocardial infarcts there was good agreement between the location of infarction and the location of resting wall motion abnormalities. Analysis of resting wall motion before propranolol indicated 18 of 75 segments (24%) to be hypokinetic and six (8%) to be akinetic. Seventy-nine per cent of these abnormal segments were in areas of previous infarction. After propranolol, 22 (14 7%1 ) were less hypokinetic.
Discussion
Propranolol is currently the major beta-blocker used in the treatment of patients with angina pectoris. Since it is so frequently used, it is important that its effect on left ventricular function is characterised thoroughly both at rest and during exercise. This study was performed to assess the effect of oral propranolol on rest and exercise left ventricular end-diastolic and end-systolic volumes, stroke volume, cardiac output, and ejection fraction, all assessed during supine exercise with multigated equilibrium blood pool imaging. Recent developments with this radionuclide technique have shown it to be a reliable and reproducible method for the measurement of these indices of left ventricular function and segmental wall motion. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] In the patients studied, propranolol resulted in lower resting and exercise heart rates and double products. In addition, propranolol administration was associated with substantial improvement in exercise induced angina and/or work performance in most patients. These 
